Polarized liquid nitroglycerin plus magnesium sulfate Efficacy of treatment of pulmonary heart failure.docVIP

 PAGE \* MERGEFORMAT 8 Polarized liquid nitroglycerin plus magnesium sulfate Efficacy of treatment of pulmonary heart failure [Abstract] Objective To observe the polarized liquid nitroglycerin plus magnesium sulfate treatment of pulmonary heart disease heart failure patients. Methods in patients with chronic pulmonary heart failure 72 patients were randomly divided into treatment group and control group 36 patients in the control group received conventional treatment, that is, bed rest, continuous low flow oxygen, limiting sodium intake, antibiotics, proper use of diuretic, tonic, etc., the treatment group on the basis of conventional therapy plus 25% magnesium sulfate 10ml, 10% potassium chloride 10ml, insulin 4 to 8 units, nitroglycerin 5 ~ 10mg, adding 10% glucose 500ml within 10 ~ 15g per minute rate of intravenous drip, day 1 for 7 to 10 days. compared the two groups before and after treatment in patients with NYHA class and cardiac left ventricular function ventricular ejection fraction (EF), cardiac output (CO) and cardiac diastolic function indices peak E and A peak (E / A). Results treatment group (heart function improved more than grade , 24 cases), effective rate 66.7%, the conventional treatment group 11 cases, effective rate is 30.5%. the efficiency of the two groups were compared, the difference was statistically significant, treatment group and control group before and after left ventricular ejection fraction, heart rate, output and peak E diastolic function parameters compared with the A peak ratio, the difference was statistically significant. Conclusion polarized liquid nitroglycerin plus magnesium sulfate treatment of pulmonary heart failure effect is significant. [Keywords:] nitroglycerin and magnesium sulfate polarized liquid, pulmonary heart failure Chronic pulmonary heart disease (chronic pulmonary heart disease) is due to chronic lung and thoracic disease, or pulmonary vascular disease caused by increased pulmonary vascular resi